Akcea Therapeutics, Inc.
(NASDAQ : AKCA)

( )
AKCA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.14%42.140.9%$1149.17m
LLYEli Lilly and Company
0.06%122.731.0%$1042.43m
JNJJohnson & Johnson
-0.25%135.080.6%$980.86m
MRKMerck & Co., Inc.
0.50%79.830.6%$948.36m
BMYBristol-Myers Squibb Company
-2.24%50.151.4%$769.39m
ABBVAbbVie, Inc.
-1.56%78.742.2%$656.42m
AZNAstraZeneca PLC Sponsored ADR
0.57%40.661.3%$194.26m
NVSNovartis AG Sponsored ADR
-0.20%90.330.2%$186.53m
GSKGlaxoSmithKline plc Sponsored ADR
-0.84%40.200.2%$135.43m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.08%49.660.1%$70.22m
SNYSanofi Sponsored ADR
-0.15%41.270.2%$36.80m
LCILannett Company, Inc.
-4.69%9.3436.7%$16.40m
AKTXAkari Therapeutics Plc Sponsored ADR
1.07%1.891.7%$0.06m
EPIXESSA Pharma Inc
-5.33%3.550.1%$0.04m

Company Profile

Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs fro the treatment of cardio metabolic diseases caused by lipid disorders. Its products include novel drugs under the followng brands: volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.